About Us

Our Conference

The Boston Investment Conference gathers the brightest minds in the investment community together for a full day of insights, ideas and networking. Each year, conference proceeds benefit a new research initiative at Boston Children's, as well as unique collaborations between Boston Children's and the Broad Institute.

Your Impact

Since inception in 2012, the Boston Investment Conference has generated more than $22M to accelerate the most promising research aimed at curing incurable diseases and improving health for children everywhere. Life-changing innovations supported through the Boston Investment Conference include next-generation cancer diagnostics, enhanced gene therapy and an optimized COVID-19 vaccine.

About Boston Children's

Boston Children's has been quietly changing the future of health for children everywhere since 1869. Named the number one pediatric hospital for eight years in a row, Boston Children's is also the largest research center for pediatric medicine anywhere.

We have a legacy of medical breakthroughs; many leading to treatments for adults. Discoveries include the first measles vaccine, the first remission of leukemia and the first solid organ transplant. We have been home to two Nobel Laureates, eight Lasker Award (America's Nobel) winners and four MacArthur ``Genius Grant`` Fellows. Boston Children's receives more NIH grants than any other pediatric institution.


Check back for additional speaker announcements.
For a full list of our previous speakers, click here.

Keith Block

Smith Point Capital

Bernard P. Cooney III

Flagship Pioneering

Will Danoff

Fidelity Contrafund

David Fialkow

General Catalyst

Phill Gross

Adage Capital Management, L.P.

Jean M. Hynes

Wellington Management

BIC Speaker

Kris Jenner

Rock Springs Capital

Seth A. Klarman

The Baupost Group

Adam M. Koppel

Bain Capital Life Sciences

Kim Y. Lew

Columbia Investment Management Company, LLC

Marc Lore

Wonder Group

BIC Speaker

Adam Mikkelson

Camber Capital

Jim Mooney

The Baupost Group

Michael E. Murphy

Kensington Avenue Strategies

Evan Rachlin

Evan Rachlin

Ascenta Capital

David M. Rubenstein

The Carlyle Group

Robert F. Smith

Vista Equity Partners

Krishna Yeshwant

Google Ventures